Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gold

Showing results (851-860 of 1,272) with videos related to

Pageof 128
Sort By:
Current Alzheimer Research|May 20, 2011
Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studiesC Harrington, S Sawchak, C Chiang, et al.
Psychophysiology|November 19, 2011
Response activation impairments in schizophrenia: evidence from the lateralized readiness potentialEmily S Kappenman, Samuel T Kaiser, Benjamin M Robinson, et al.
International Journal of MS Care|December 11, 2024
Acceptability and Feasibility of the English Version of Elevida, a Self-Guided Online Fatigue Intervention for People With Multiple SclerosisJo Lane, Carmel Poyser, Yixuan Zhao, et al.
JCI Insight|January 11, 2024
CD3 downregulation identifies high-avidity, multipotent SARS-CoV-2 vaccine- and recall antigen-specific Th cells with distinct metabolismArne Sattler, Stefanie Gamradt, Vanessa Proß, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 5, 2008
Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcersJames A Waltz, Julie B Schweitzer, James M Gold, et al.
Frontiers in Neurology|October 29, 2020
Altered Coupling of Psychological Relaxation and Regional Volume of Brain Reward Areas in Multiple SclerosisKatharina Wakonig, Fabian Eitel, Kerstin Ritter, et al.
BMC Medical Research Methodology|August 15, 2022
On model-based time trend adjustments in platform trials with non-concurrent controlsMarta Bofill Roig, Pavla Krotka, Carl-Fredrik Burman, et al.
Neuroimage|July 26, 2011
Apathy, depression, and motor symptoms have distinct and separable resting activity patterns in idiopathic Parkinson diseaseF M Skidmore, M Yang, L Baxter, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
Inferior petrosal sinus arginine vasopressin concentrations in normal volunteers and patients with Cushing's diseaseT C Friedman, J A Yanovski, L K Nieman, et al.
Schizophrenia Bulletin Open|July 8, 2022
Linking Salience Signaling With Early Adversity and Affective Distress in Individuals at Clinical High Risk for Psychosis: Results From an Event-Related fMRI StudyZachary B Millman, Jason Schiffman, James M Gold, et al.
Pageof 128

Showing results (851-860 of 1,272) with videos related to

Sort By:
Pageof 128
Current Alzheimer Research|May 20, 2011
Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studiesC Harrington, S Sawchak, C Chiang, et al.
Psychophysiology|November 19, 2011
Response activation impairments in schizophrenia: evidence from the lateralized readiness potentialEmily S Kappenman, Samuel T Kaiser, Benjamin M Robinson, et al.
International Journal of MS Care|December 11, 2024
Acceptability and Feasibility of the English Version of Elevida, a Self-Guided Online Fatigue Intervention for People With Multiple SclerosisJo Lane, Carmel Poyser, Yixuan Zhao, et al.
JCI Insight|January 11, 2024
CD3 downregulation identifies high-avidity, multipotent SARS-CoV-2 vaccine- and recall antigen-specific Th cells with distinct metabolismArne Sattler, Stefanie Gamradt, Vanessa Proß, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 5, 2008
Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcersJames A Waltz, Julie B Schweitzer, James M Gold, et al.
Frontiers in Neurology|October 29, 2020
Altered Coupling of Psychological Relaxation and Regional Volume of Brain Reward Areas in Multiple SclerosisKatharina Wakonig, Fabian Eitel, Kerstin Ritter, et al.
BMC Medical Research Methodology|August 15, 2022
On model-based time trend adjustments in platform trials with non-concurrent controlsMarta Bofill Roig, Pavla Krotka, Carl-Fredrik Burman, et al.
Neuroimage|July 26, 2011
Apathy, depression, and motor symptoms have distinct and separable resting activity patterns in idiopathic Parkinson diseaseF M Skidmore, M Yang, L Baxter, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
Inferior petrosal sinus arginine vasopressin concentrations in normal volunteers and patients with Cushing's diseaseT C Friedman, J A Yanovski, L K Nieman, et al.
Schizophrenia Bulletin Open|July 8, 2022
Linking Salience Signaling With Early Adversity and Affective Distress in Individuals at Clinical High Risk for Psychosis: Results From an Event-Related fMRI StudyZachary B Millman, Jason Schiffman, James M Gold, et al.
Pageof 128